Clinical Trials
28 trialsPALANGI3
Centre Oscar Lambret
An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma
Mayo Clinic
Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
PRIMHADRON
Hospices Civils de Lyon
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
National Cancer Centre, Singapore
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
Memorial Sloan Kettering Cancer Center
Meteor 1
GlaxoSmithKline
Surgical Strategy for Head and Neck Adenoid Cystic Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
ROOT
Taproot Health
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
M.D. Anderson Cancer Center
ACCURACY
Ayala Pharmaceuticals, Inc,
Understanding the Burden of ACC Through the Eyes of Patients
Ayala Pharmaceuticals, Inc,
LUPSA
Radboud University Medical Center
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies
Prelude Therapeutics
MYPHISMO
Peter MacCallum Cancer Centre, Australia
A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma
Dana-Farber Cancer Institute
Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Dana-Farber Cancer Institute
Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)
Fudan University
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck
University of Iowa
ACC
University of Virginia
PSMA-PET Imaging for Advanced ACC/SDC
Radboud University Medical Center
Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC)
M.D. Anderson Cancer Center
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Novartis
Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
University of Pittsburgh
A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
University Health Network, Toronto
ACCRAD001
Seoul National University Hospital
Dovitinib in Adenoid Cystic Carcinoma
Seoul National University Hospital